Preview

The Case of the Sole Remaining Supplier

Good Essays
Open Document
Open Document
365 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
The Case of the Sole Remaining Supplier
As the story of the Sole Remaining Supplier was told to me, the Board conversation went pretty much the way the case describes it. Legal was saying, "This is a time bomb waiting to happen. Why are we even talking about this?" Engineering was bemoaning the lack of standards for testing the electronics of pacemakers, and the majority of the Board understood that they had a problem with no easy solution.
One of the people on the Board told me later that the founders of Silicon Valley were the sons (and a few daughters) of blue-collar parents. Their fathers were plumbers, electricians, and carpenters, who had passed on a core set of values to their children. This was the Valley before greed and early retirement (at the age of 30) had swept through it. So they took seriously their responsibility and duty to protect the rights of people who needed pacemakers at the same time as they balanced their fiduciary responsibility to the current company. They understood that "doing the right thing" did not have to be stupid, and that they could both do the right thing and do well for the company ("DO RIGHT" AND "DO WELL," rather than having to choose one or the other.)
So, they continued to sell to the pacemaker company. But they also instructed their engineers to develop more rigorous testing and technical standards they could hold the other company to. They reserved the right to stop selling if the other company did not improve its technical standards. They took steps to be sure they did not have a legal liability down the line and then turned it over to the other company to improve the quality of its products.
In these ways they felt they were reducing harms and maximizing utility. They felt it fair to single out the industry because it was new and standards were developing, an equal way of treating start-up industries. They felt they were showing compassion without sacrificing business, and were living out their parents' other virtues. In this way they felt that they were

You May Also Find These Documents Helpful

  • Good Essays

    Biomax Case Summary

    • 1049 Words
    • 5 Pages

    Clive Meanwell is a bit of a scavenger. He established an organization four years back focused around the thought that there was cash to be made from medications that different organizations set aside. The first assignment for Meanwell and his partners was choosing what medications to save. The strategy was risky as there were half chances that this medicine will work or not so it was total gamble from Meanwell point of view. In the year of 1997, they had settled on Angiomax, an against blood-coagulating medication that Biogen had been creating as a more viable option to heparin, the opposition to thickening medication most broadly utilized as a part of the intense treatment of coronary heart disease. Upon looking into Biogen's clinical test outcomes, on the other hand, Meanwell had believed that a business still existed for the medication. In this way, in March 1997, the Medicines Company procured all rights to Angiomax and set out to finish the clinical trials that Biogen had started upon securing Angiomax in 1997, the Medicines Company set out to address a few issues. First and foremost, the organization led an affirming clinical study utilizing high risk angioplasty patients, second, in 1999 the Medicines Company contracted out creation of Angiomax to UCB Bioproducts, with the comprehension that UCB would endeavor to create a second-era assembling techinque to cut down the expense of generation. The Medicines Company raised almost 10 millions dollars to improve the…

    • 1049 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Case Assignment

    • 631 Words
    • 3 Pages

    Bret O’Brien works for MediSys Corporation as a manager in product engineering. First employed at the company in 1995, he is experienced in his field having previously led the engineering effort for pulmonary systems. O’Brien has been rated a high performer and was personally groomed for a managerial role by Len Broman the Vice President of Design and Engineering. He was one of the original members of the ad hoc group that formed to create the early development of the patient monitoring system to be used in hospitals’ intensive care units later named IntensCare. O’Brien was then included in the formalized core team put together by Art Beaumont. His responsibility is to ensure that the software and hardware’s forms will be finalized by May 1st.…

    • 631 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    As per the court documents, the companies were aware of the defective product, but continued selling it without informing the public with respect to their risks. Although the IVC filters were designed by the manufacturers to prevent pulmonary embolism which is life-threatening, they avoided informing people about the side effects which are life-threatening. As per the report which was released in 2010, the FDA has received more than 900 reports of adverse events which are associated with the IVC…

    • 366 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Wound Care Case Study

    • 596 Words
    • 3 Pages

    The buyers entered this market at a right time and maybe to late but based on the technology jump they are making it was perfect time. Inly problem being is health care plan act passed by Obama is hurting profits due to not getting the insurance money that they get from the past but are getting the minimum pay from the act. This has hurt hospitals, ER, and even private doctors. The act is great for the patience but for the business it hurt you lose money when you are saving lives and can’t pay for the new technology or equipment based on the loss of profit from all the company’s. Rich talked about they have lost interest due to the size of investment it would be to get bought out and they will continue to grow this business due to the lost…

    • 596 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Acc 556 Assignment 2

    • 4988 Words
    • 12 Pages

    Biomet 3I is the company I have been working for since 2007. Biomet, Inc. is a medical device headquartered in the Warsaw, Indiana business cluster. This company specializes in reconstructive products for orthopedic surgery, neurosurgery, craniomaxillofacial surgery and operating room supplies, and dental implants. Established in 1977, it delivered its first hip replacement in 1978. But in September 2007 during a club deal this enterprise was acquired by a consortium of private equity firms consisting of the Blackstone Group, Goldman Sachs, Kohlberg Kravis Roberts L.P. and TPG Capital before pertaining to four investors whose names are Dane A. Miller, Ray Harroff, Niles Noblitt, and Jerry Ferguson. In 2010, during the time of the great recession, the top management of this manufacture laid off 250 people out 9200 while opening two other branches overseas in Spain and in China. Apparently some issues arise in the financial system of this company which makes it over budget with a deficit 3.5 million according to a Team member in the accounting department.…

    • 4988 Words
    • 12 Pages
    Powerful Essays
  • Powerful Essays

    Stark Law

    • 2981 Words
    • 12 Pages

    Monday, February 13, 2006: Iowa Methodist Hospital Settles Fraud Claim. “An Iowa lawsuit alleging that Iowa Methodist Hospital pressured physicians to use specific pacemakers in order to get rebates from the manufacturer has been settled…” (MedLaw).…

    • 2981 Words
    • 12 Pages
    Powerful Essays
  • Satisfactory Essays

    Erik Peterson was hired as the Product Manager in charge of sales and marketing of Biometra’s catheter, shortly after completing his MBA. Due to sudden resignation of the Vice President of peripheral and vascular devices as well as certain key Biometra managers, Peterson was promoted to be the Acting General Manager (GM). From the case we see that even though Erik Peterson tries hard to meet the product target launch date, there are several issues that he and the organization are experiencing.…

    • 816 Words
    • 4 Pages
    Satisfactory Essays
  • Good Essays

    Geron the first company to get the green light for trials, quit and is selling that part of the business…

    • 718 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Chemistry in the News

    • 1779 Words
    • 5 Pages

    Brandon England is one of those people. He was diagnosed with dilated cardiomyopathy putting him at risk for dangerous arrhythmias that could be fatal if not corrected quickly. He was implanted with an internal cardiac defibrillator, ICD for short, to help stop those arrhythmias almost instantaneously. Typically ICD’s need to have a direct connection to the heart to detect the heart’s rhythm. Those connections are called leads. Brandon’s IDC is different though. Its wireless and doesn’t require those leads that go to the heart. It’s the first of its kind to be implanted in Utah and will hopefully continue to be used to help prevent sudden cardiac arrest.…

    • 1779 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Medisys Case Analysis

    • 1632 Words
    • 7 Pages

    The medical device manufacturing industry in 2009 was already competitive with future expectations of increased competition, when two deep pocketed, highly reputable public companies announced plans to launch additional product segments. Product development within the industry was both expensive and complicated. Firms were forced to meet strict quality and regulatory standards, sometimes including lengthy clinical trials, before final product distribution.…

    • 1632 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    Holding Fast Case Study

    • 1455 Words
    • 4 Pages

    1. This case starts out in a lab that is located in a building that is operated by Crescordia. Crescordia is a company that makes a range of products such as artificial hips and scalps but also is one of the few companies that sell fixation devices. At the beginning of the case Crescordia holds a seminar for orthopedic surgeons so they can better familiarize themselves with the products and procedures that are needed when dealing with using these fixation plates. During this seminar the CEO Peter Walsh enters excitedly to see what is going on. You can tell right from the start that he is a very big people person and is incredibly interested in finding out the needs and what surgeons are saying about the products that he puts out. After Peter Walsh enters the seminar is put on hold and they all go out to lunch. During lunch one of the surgeons launched into a story about having to remove a resorbable plate, which are fixation devices that instead of having to be removed by doctors after the bone is healed these would just disintegrate after the bone had been healed which would mean that you would not have to have surgery again to remove the plate. The story however takes a sad turn as you find out that most resorbable plates have a lot of problems that have not been figured out and is still a technology that is not capable of doing what it says. The surgeons asked Peter Walsh when Crescordia would plan to launch its own resorbable’s and his response was that Crescordia is a company that has a reputation for quality and that resorbable’s were not at the stage where they would live up to what they set out to do. Resorbable’s are a huge potentially untapped market so Peter Walsh made it his first priority to find out where Crescordia is at with its resorbable’s. He talked with Gary Miskimen who is the head of R&D. He basically confirmed to Walsh that resorbable’s still are not perfect and that they could not do any more lab…

    • 1455 Words
    • 4 Pages
    Powerful Essays
  • Good Essays

    Gorman, C. and Park, A. (July 2001). “The Artificial Heart, Revisited,” Time, vol, 158, issue 2, pp. 76. Retrieved March 3, 2008 from http://www.time.com/time/magazine/article/0,9171,1000338,00.html…

    • 571 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Dr. Romach Case

    • 1072 Words
    • 5 Pages

    John Cannon graduated from a prestigious West coast university where he majored in international business and had been a very successful biotechnology market analyst early in his career. He then joined and became a manger for (IML) International Medical Laboratories, a large biomedical equipment company managing the German subsidiary. IML specializes in expensive, high quality heart and lung machines that are used during open heart surgery. John’s job title was that of a manager and he was to be in charge of marketing their line internationally, he targeted Europe.…

    • 1072 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Monica Ashley Case

    • 673 Words
    • 3 Pages

    Monica Ashley was a bright employee at Health Equipment and Laboratories, Inc. (HEAL-INC), an advanced diagnostic and treatment equipment manufacturer. She was appointed manager of “Project Hippocrates” by Gary Dorr, the President of HEAL-INC. The purpose of this project was to shift from analog to digital electronics by purchasing digital components from an outside vendor. Since this was the industry trend, it would only be logical for all the divisions within the company to readily accept the project. Unfortunately for Monica, this was not the case.…

    • 673 Words
    • 3 Pages
    Good Essays
  • Best Essays

    Allied Health Care Products

    • 4278 Words
    • 18 Pages

    Munsey, R. R. (1995). Trends and Events in FDA Regulation of Medical Devices Over the Last Fifty Years. Food and Drug Law Journal 50, Special Issue, 163-177.…

    • 4278 Words
    • 18 Pages
    Best Essays